A Novel Treatment for Office Aspiration Curettage in Cases of Retained Products of Conception: A Randomized Controlled Trial

Published: 8 March 2021| Version 1 | DOI: 10.17632/zv927j56jy.1
Nissim Arbib,
Meir Pomeranz,
Nitzan Goren Gepstein,
Michal Ovadia,
Yair Daykan,
Ron Schonman


This study evaluated the success rate of Karman aspiration cannula in evacuating retained products of conception after failed misoprostol treatment, without the need for additional hysteroscopy. We found that office aspiration for the management of residua after missed abortion, with no need for anesthesia or analgesia is a feasible solution that avoids operative time and costs. Data were abstracted from EMR.